Mivelsiran Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ALN-APP

Pipeline

Phase 2: 1

Top Sponsors

Alnylam Pharmaceuticals1

Indications

Down Syndrome-Associated Alzheimer's Disease (DS-AD)1
Alzheimer's Disease1

Maitland, Florida1 trial

A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

Clinical Study Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.